Clinical trial
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
NCT01421134
Study timeline
Study start (unknown)2011-09-01Date precision: month
Registry last updated2016-07-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
LurasidoneDRUG · verified · RxNorm: lurasidone
PlaceboDRUG
Sponsors & collaborators
Sumitomo Pharma America, Inc.lead sponsor
Mapped research locations
Saint PetersburgRussia3DallasTexas, United States2BelgradeSerbia2SaratovRussia2New YorkNew York, United States1BostonMassachusetts, United States1PhiladelphiaPennsylvania, United States1BirminghamAlabama, United States1San DiegoCalifornia, United States1DurhamNorth Carolina, United States1RochesterNew York, United States1ManchesterUnited Kingdom1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01421134 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.